“Dream team” science helps move Ontario ahead of the curve on hard-to-treat cancers

Ontario Institute for Cancer Research announces funding for sixteen studies that support early detection of cancer, the development of new diagnostics to guide therapy and improved treatment options for patients

OICR appoints Dr. Steven Gallinger as Head, Clinical Translation

OICR research leads to new pancreatic cancer clinical trial with aim to change the standard of care for patients

Philanthropic donation moves The Alex U. Soyka Pancreatic Cancer Research Project: An International Partnership into Phase II

Unique Toronto-based clinical trial reveals new subtypes of advanced pancreatic cancer

Canadian pancreatic cancer research team provides personalized medicine, new hope to patients

Early results from COMPASS trial demonstrate benefits of using genomic sequencing to guide treatment for pancreatic cancer

OICR launches five all-star teams of Ontario scientists to tackle some of the deadliest forms of cancer

OICR launches five large-scale Ontario research initiatives to combat some of the most deadly cancers

OICR researchers to be part of Cancer Research UK’s Grand Challenge helping to answer cancer’s biggest questions

OICR-led study finds four unique genomic signatures in pancreas cancer, uncovers potential of immunotherapies

New findings challenge current view of how pancreas cancer develops

The Ontario Institute for Cancer Research invests $4.6 million to support pancreatic cancer research